Price$0.62+0.04 (+7.71%)
01:45 PM07:45 PM
News · 26 weeks560%
2026-04-192026-10-11
Mix2290d
- Other10(45%)
- Insider6(27%)
- SEC Filings4(18%)
- Earnings2(9%)
Latest news
25 items- SECSEC Form 8-K filed by SenesTech Inc.8-K - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential GrowthSURPRISE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026. The Company plans to release its definitive third quarter financial results the week of November 9, 2026. Preliminary third quarter 2026 revenue was approximately $1.1 million, representing approximately 40% growth compared with the second quarter of 2026 and approximately 55% growth compared with the third quarter of 2025. It was also the Company’s first quarter at or above the $1 million revenue threshold, a key milestone. The Company expects its def
- PRSenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential GrowthPreliminary Revenue of $1.1 Million is the Highest Quarterly Revenue in the Company's HistorySURPRISE, Ariz., Oct. 15, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced preliminary revenue results for the third quarter of 2026. The Company plans to release its definitive third quarter financial results the week of November 9, 2026.Preliminary third quarter 2026 revenue was approximately $1.1 million, representing approximately 40% growth compared with the second quarter of 2026 and approximately 55% growth compared with the third quarter of 2025. It was also the Company's first quarter at or ab
- INSIDERChief Executive Officer Edell Michael bought $1,289 worth of shares (2,000 units at $0.64), increasing direct ownership by 22% to 11,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- PRSenesTech Expands Third-Party E-commerce Distribution with Grove Collaborative, Bringing Evolve® Rodent Birth Control™ Products to Sustainability-Focused ConsumersSURPRISE, Ariz., Sept. 23, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Evolve® family of rodent birth control products will soon be available through Grove Collaborative's online marketplace. The launch will expand consumer access to an innovative rodent control solution for environmentally conscious households. Grove Collaborative is a leading sustainable consumer products marketplace offering products that meet rigorous standards for sustainability, ingredient transparency and performance. Its customers are high
- PRSenesTech to Participate in the Lytham Partners Fall 2026 Investor ConferencePHOENIX, Sept. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29-30, 2026. Company WebcastThe webcast presentation will take place at 2:00 p.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/zVDkW93n62b. The webcast will also be available
- INSIDERChief Executive Officer Edell Michael bought $840 worth of shares (1,000 units at $0.84), increasing direct ownership by 12% to 9,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERChief Executive Officer Edell Michael bought $1,740 worth of shares (2,000 units at $0.87), increasing direct ownership by 33% to 8,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- PRSwampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity with Evolve® RatSURPRISE, Ariz., Aug. 31, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced that a six-month deployment of Evolve® Rat as part of a comprehensive Integrated Pest Management program reduced measured rodent activity by 43% at a municipal facility in Swampscott, Massachusetts. Municipalities across the country are increasingly seeking more effective, sustainable approaches to reducing rodent populations while minimizing reliance on repeated rodenticide applications. The six-month deployment in Swampscott demonstrates how rodent birth
- PRSenesTech Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)SURPRISE, Ariz., Aug. 27, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales. The award was granted under the SenesTech, Inc. 2026 Inducement Plan as a material inducement to Mr. Karabees entering into employment with SenesTech, in accordance with Nasdaq Listing Rule 5635(c)(4).The inducement award, granted on Aug. 25, 2026, consists of a nonstatutory stock option to purchase 108,
- SECSEC Form S-8 filed by SenesTech Inc.S-8 - SenesTech, Inc. (0001680378) (Filer)
- INSIDERChief Executive Officer Edell Michael bought $1,210 worth of shares (1,000 units at $1.21), increasing direct ownership by 20% to 6,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- PRSenesTech to Participate in the Lytham Partners 2026 Consumer & Technology Investor Summit on August 18, 2026SURPRISE, Ariz., Aug. 17, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026. The webcast will take place at 1:30 p.m. ET on Tuesday, August 18, 2026. The webcast can be accessed by visiting the summit home page at https://lythampartners.com/cts2026/ or directly at https://lythampartners.com/cts2026/snes. A replay will also be available through the same links.About SenesTechSene
- INSIDERLarge owner Glenbrook Capital Management bought $27,865 worth of shares (21,490 units at $1.30) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- SECSenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-commerce Growth AcceleratesRevenue rose 56% sequentially and gross margin reached a company-record 73.6% in the first full quarter of in-house Amazon management, advancing the Company's intended shift to a scalable, recurring-revenue platform.SURPRISE, Ariz., Aug. 5, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, today announced financial results for the second quarter ended June 30, 2026. Q2 2026 Financial HighlightsTotal revenue increased 56% to a record $770,000 in Q2 2026, compared to $493,000 in Q1 2026
- PRSenesTech Adds Assessment Services to Help B2B Customers Better Understand Rodent InfestationsNew assessment services complement existing implementation and deployment services to develop the most effective solution for each customer's rodent problem.SURPRISE, Ariz., Aug. 5, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in rodent birth control solutions, today announced the introduction of assessment services designed to help B2B customers better understand the scope of rodent infestations and develop more effective long-term strategies. The new services further strengthen SenesTech's approach to helping customers achieve more effective rodent population management. The new assessment services complement
- SECSenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - SenesTech, Inc. (0001680378) (Filer)
- PRSenesTech Active Subscriber Base More Than Doubles as E-commerce Strategy Gains MomentumIntegrated e-commerce strategy drives recurring revenue while supporting long-term growth across consumer and business-to-business markets.SURPRISE, Ariz., Aug. 3, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), the leader in rodent birth control solutions, today announced that its active online subscription customer base, comprising both direct-to-consumer ("DTC") and business-to-business ("B2B") customers, more than doubled during the second quarter of 2026 compared to the first quarter, reaching a record level. That expansion reinforces the Company's recurring revenue model while potentially increasing customer lifetime value and improving long-term revenue visibility.
- PRSenesTech to Report Second Quarter 2026 Financial Results on Wednesday, August 5, 2026Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, July 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control solutions for managing rodent populations, will report financial results for its second quarter 2026, ended June 30, 2026, after the market close on Wednesday, August 5, 2026. The Company has scheduled a conference call that same day, Wednesday, August 5, 2026, at 5:00 pm ET, to review the results. Second Quarter 2026 Conference Call DetailsDate and Time: Wednesday, August 5, 2026, at 5:00 p.m. Eastern timeLive Webcast In
- SECSEC Form SCHEDULE 13D filed by SenesTech Inc.SCHEDULE 13D - SenesTech, Inc. (0001680378) (Subject)
- INSIDERLarge owner Glenbrook Capital Management bought $51,569 worth of shares (35,000 units at $1.47) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- PRSenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural OperationSURPRISE, Ariz., July 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control solutions for managing rodent populations, today announced successful results from the use of Evolve® Rat Birth Control™ at a 400-acre farming operation in Dalhart, Texas, where rodents had been causing persistent damage to underground irrigation infrastructure. The farm utilizes one of the world's leading irrigation systems for precision agriculture and sustainable water management. Prior to implementing Evolve, rodents routinely chewed through underground irrigation tape in search of water in the dry Texas climate, resul
- INSIDERChief Executive Officer Edell Michael bought $1,430 worth of shares (1,000 units at $1.43), increasing direct ownership by 25% to 5,000 units (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
- INSIDERLarge owner Glenbrook Capital Management bought $52,731 worth of shares (35,000 units at $1.51) (SEC Form 4)4 - SenesTech, Inc. (0001680378) (Issuer)
SNES FAQ
6 questionsWhat does SenesTech Inc. do?
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait that limits reproduction of male and female rats. It is also developing a pipeline of fertility control and animal health products, including feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.Where does SNES stock trade?
SenesTech Inc. (SNES) is listed on NASDAQ.What sector and industry is SNES in?
SenesTech Inc. operates in the Industrials sector, Agricultural Chemicals industry.When did SenesTech Inc. go public?
SenesTech Inc. (SNES) completed its IPO in 2016.What companies are similar to SNES?
Notable peers in the same industry include NTR (Nutrien Ltd.), CF (CF Industries Holdings Inc.), ICL (ICL Group Ltd.), MOS (Mosaic Company), SMG (Scotts Miracle-Gro Company). Compare SNES side-by-side with any of them on Quantisnow.How can I track SNES on Quantisnow?
Quantisnow aggregates SenesTech Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SNES to receive live email and push alerts on every new disclosure.